Arcellx Provides First Quarter 2024 Financial ResultsArcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today...
Business Wire•3 months ago